Life Sciences Institute of New Jersey (LSINJ), Belle Mead, NJ, USA. - Selected & Relevant Publications, Donations & Statement.

SELECTED PUBLICATIONS - LSINJ

(Selected Publications Relevant to the Mission of the LSINJ )

Akin to the Great Revolutions or Ages, the Combinatorial Approach for Preempting Genetic Diseases Requires the Confluence of Independent Scientific and Societal Developments Emerging from Synergisms Between Serendipitous, Planned and Natural Progressions Significantly Magnifying the Impact Over the Simple Sum of their Individual Components or Subfields

Ferez Soli Nallaseth1*, et al ,*Corresponding Author: Ferez Soli Nallaseth, Founding President, CEO, CSO and CFO for the LSINJ, USA. Postal Addresses: Life Sciences Institute of New Jersey, Email: FerezNallaseth@LifeSciencesInstituteNJ.com; https://actascientific.com/ASMI/pdf/ASMI-04-0918.pdf

Shifting the therapeutic paradigm in medicine from post mutational (& pathological) intervention to preemption – a synopsis of the ‘nuts and bolts’ Ferez S. Nallaseth, MS, PhD, MOJ Proteomics Bioinform. 2019;8(2):41‒43.DOI: 10.15406/mojpb.2019.08.00264

What is the Life Sciences Institute of New Jersey? Why and how does it exist? What are its goals? Ferez S. Nallaseth, MS, PhD, Mol Biol OMIC 2015, 4: 3, (2168 - 9547 - 1000130.php?aid=60692) doi: 10.4172/2168-9547.100130

https://www.hilarispublisher.com/open-access/what-is-the-life-sciences-institute-of-new-jersey-why-and-how-does-itexist-what-are-its-goals-2168-9547-1000130.pdf

Is There a Role for an Evolutionary Genetics Based Rational Health Policy In Global Biomedical, Health and Economic Policies? Nallaseth. J. Mol Biol OMICS . v3 :1.6.30.2014, (http://dx.doi.org/10.4172/2168-9547.1000e118)

Is There A Role for an Evolutionary Genetics Based Rational Health Policy In Global Biomedical, Health and Economic Policies? Nallaseth. Mol Biol OMICS (http://dx.doi.org/10.4172/2168-9547.1000e118 )

https://www.academia.edu/53804000/Is_There_a_Role_for_an_Evolutionary_Genetics_Based_Rational_Health_Policy_In_Global_Biomedical_Health_and_Economic_Policies

Issues raised below are also addressed above:

(1) http://kingsreview.co.uk/magazine/blog/2014/02/24/how-academia-and-publishing-are-destroying-scientific-innovation-a-conversation-with-sydney-brenner/

(2)Rescuing US biomedical research from its systemic flaws

Bruce Alberts, Marc W. Kirschner, Shirley Tilghman smt@princeton.edu, and Harold Varmus Authors Info & Affiliations

Edited by Inder M. Verma, The Salk Institute for Biological Studies, La Jolla, CA, and approved March 18, 2014 (received for review March 7, 2014)

April 14, 2014, 111 (16) 5773-5777; https://doi.org/10.1073/pnas.1404402111; http://www.pnas.org/content/early/2014/04/09/1404402111).

LinkedIn Pulse Post (censored on LI) - Antecedents in Soviet Dissent & US Garage Enterprises - Citizen Scientist, the LSINJ & the Public Interest!

LinkedIn Pulse Post - Asilomar Revisited! The debate on the non-issue that is CrispR/Cas9 & why it detracts from the basic obligation of Humankind!

LinkedIn PulsePost - Updated! What Is Lost In Confronting Global Health & Economic Crises? Scale! Science & Cost - Benefit Ratios Overwhelmingly Support Marshall Plan Based Preemption! 2.9.2016.pdf

http://pharmaceuticalintelligence.com/2015/05/10/a-patients-perspective-on-open-heart-surgery-from-diagnosis-and-intervention-to-recovery/

Re-inventing the Paradigm into which Global Health Policy is Locked: the Destructive Impact of Drift in Initiating Preemptive Intervention With All its Human, Economic & Medical Consequences!

Shifting the Therapeutic Paradigm in Medicine from Post Mutational (& Pathological) Intervention to Preemption – A Synopsis of the ‘Nuts and Bolts’ - Systematization, Surveillance & Control of the Networks of Genes Maintaining the Human Genome in Real Time, Ferez S. Nallaseth, MS, PhD, (MOJPB, 2018) https://medcraveonline.com/MOJPB/MOJPB-08-00264.pdf

Serendipitous contributions of the LSINJ as a consequence of its core scientific mission of preempting genetic disease lesions - a Public Service. Addressing a significant driver of the COVID - 19 Pandemic by preempting the generation of mutations in viral genomes e.g. SARS-Cov-2.

Multi-dimensional factors driving the pandemic and how their impact decides any return to the pre-COVID-19 world! (How and when should we begin playing Squash? As with everything in the post COVID-19 world - considering the stakes – very slowly and carefully!)

Kholis Abdurachim Audah Ph.D.$, Dickson Achimugu Musa Ph.D.#, David Adebayo, Syed Mahmood Ahmed Ph.D., Alex Diaz Ph.D., Abhishek Gupta Ph.D., Percy Ichchaporia M.S., Anthony Lai M.B.B.S., M.D., F.A.C.O.G., Lori McGrew Ph.D.++, Moyosola Otusanya M.S., Elizabeth Parrish, Jean Plante@, Asmaa Rabit D.G.M. & D., Ralph Sherman B.S., Sina Varmaghani M.S., Collin C. White B.S., Nirmali Wijegoonawardana Ph.D., Rebecca Xu, Hafiz Yahya Ph.D., Poorna C.R. Yalagala Ph.D., Osama Youssef Ph.D., Alan Thatcher +1,%, George Perry Ph.D.+2,%, Ferez Soli Nallaseth, MS., Ph.D.&,+3,% , https://actascientific.com/ASMI/pdf/ASMI-04-0792.pdf

Donations - statement and methods:

Board Members of the LSINJ believe deeply in the positive impact that Science has made on Society and Humankind over thousands of years of History. However, in some cases interests of Scientific Administrations diverge from those of the Public Interest or Common Good necessitating the form of undertakings represented by the LSINJ and it's core mission as it has been sketched above. In sum this core mission is preventing Genetic Diseases and Birth Defects. Due to limitations in perceptions of Scientific Administrations and Communities about the nnecessity and feasibility of the core goals of this undertaking of the LSINJ, it can only be funded through the generosity of alternative public and private sources. We are seeking to build this alternative funding source for the LSINJ. This source will supplement the personal funds of Dr. Ferez S. Nallaseth. Over decades and millions of dollars the personal funds of Dr. Nallaseth were the major source of funding for the principal research that has matured into the current initiative of the restructured LSINJ .

The LSINJ has been granted a 501 c (3) Tax Exempt Status of a Non Profit corporation by the IRS on May 21st 2019 which has been retroactively dated to 28th December 2018. We appreciate any donations to the LSINJ that we would use to seed an investment fund for preventing Genetic Diseases and Birth Defects. As per the IRS these donations 'are tax deductible under US IRC section 170' as are 'any bequests, devices, transfers or gifts under Section 2055, 2106 or 2522.'

Currently, donations can be made via the Google Chrome Browser, the Google Browser on Apple's iPhone, Fire Fox and Internet Explorer Browsers followed by accessing PayPal through the Donate Button that is embedded below . We are in the process of improving the convenience of making donations by expanding the numbers and types of donation hosting banks and agencies.